NUNTIUS THERAPEUTICS
Nuntius Therapeutics is pioneering a new class of targeted RNA, DNA and CRISPR therapies.
NUNTIUS THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2021-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.nuntiustx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Content Delivery Network Nginx Google Apps For Business GoDaddy DNS
Similar Organizations
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Current Employees Featured
Founder
Official Site Inspections
http://www.nuntiustx.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nuntius Therapeutics"
Nuntius Therapeutics
Aug 20, 2024 · We develop transformative mRNA therapies by leveraging our ground-breaking proprietary delivery technology, machine learning and superior nucleic acid engineering.See details»
Nuntius Therapeutics - Crunchbase Company Profile
Nuntius Therapeutics develops transformative mRNA therapies by leveraging our ground-breaking proprietary delivery technology, machine learning and superior nucleic acid engineering. A technology for systemic delivery of nucleic acids …See details»
News - Nuntius Therapeutics
Aug 15, 2024 · Deals Report: Delivery play Nuntius out of stealth with Taiho cancer dealSee details»
Nuntius Therapeutics Company Profile 2024: Valuation, …
Developer of genetic medicines designed to cure patients with life-threatening diseases. The company develops mRNA therapies, and gene editing therapies by leveraging proprietary delivery technology machine learning, and nucleic acid …See details»
Nuntius Therapeutics: Cell-specific genetic medicines - Y Combinator
Cell-specific genetic medicines. Founded in 2021 by Albert Kwok and Benita Nagel, Nuntius Therapeutics has 2 employees based in London, UK.See details»
Press Release - Nuntius Therapeutics
Nuntius Therapeutics announces collaboration with Taiho Pharmaceutical to develop next-generation mRNA therapies using Nuntius’ proprietary cell-specific delivery technologySee details»
Nuntius Therapeutics - LinkedIn
Genetic medicines to cure patients with life-threatening diseases | We develop transformative mRNA therapies by leveraging our ground-breaking proprietary delivery technology, machine learning and...See details»
Nuntius Therapeutics Announces Collaboration with Taiho …
Aug 15, 2024 · Taiho will use Nuntius’ cell-specific peptide dendrimer- and lipid-based nanocarriers to develop novel mRNA cancer immunotherapies. The collaboration agreement …See details»
Nuntius Therapeutics - VentureRadar
Website: https://www.nuntiustx.com/ Develops advanced nanocarriers and mRNA for targeted therapies, leveraging machine learning to enhance treatment of cancer, lung, and …See details»
Nuntius Therapeutics Announces Collaboration With Taiho …
Nuntius Therapeutics recently announced it has entered into a collaboration agreement with Taiho Pharmaceutical Co., Ltd., a leading company in Japan for developing innovative medicines for …See details»
Nuntius Therapeutics announces collaboration with Taiho …
Nuntius Therapeutics announces collaboration with Taiho Pharmaceutical to develop next-generation mRNA therapies using Nuntius’ proprietary cell-specific delivery technologySee details»
Nuntius Therapeutics Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Nuntius Therapeutics. See Nuntius Therapeutics company profile and funding data.See details»
Nuntius Therapeutics - EU-Startups
Nuntius Therapeutics develops cell-specific DNA, RNA, and CRISPR therapies. The company was founded in 2021 and based in London, United Kingdom. We are overcoming the biggest …See details»
Albert Kwok - Nuntius Therapeutics - LinkedIn
May 19, 2020 · Please tell your colleagues in prostate cancer research about this webinar on tips for a successful grant application to Prostate Cancer Research, where I'm a trustee—an …See details»
Nuntius Therapeutics Announces Collaboration with Taiho …
Aug 15, 2024 · The company is advancing a pipeline of novel mRNA therapies targeting cancer, lung diseases and neurodegenerative diseases. Nuntius is headquartered in London, UK. For …See details»
Nuntius Therapeutics | VentureRadar
Website: https://www.nuntiustx.com/ Develops a proprietary platform technology for safe, targeted in vivo delivery, pioneering non-viral nucleic acid therapies for life-threatening diseases. …See details»
Privacy Policy - Nuntius Therapeutics
Jun 17, 2024 · This privacy policy (“Privacy Policy”) describes how and when Nuntius Therapeutics (“Nuntius”, “we”, “us” and/or “our”) collects, uses and shares your personal data …See details»
Nuntius Therapeutics - Overview, News & Similar companies
View Nuntius Therapeutics (www.nuntiustx.com) location in United Kingdom , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Nuntius partners with Taiho to develop mRNA cancer therapies
Nuntius Therapeutics Ltd. London, United Kingdom. ©2024 NuntiusSee details»
Lawrence Billing - Nuntius Therapeutics - LinkedIn
Sep 30, 2022 · Thrilled about our collaboration with Taiho to improve treatments for cancer patients. Looking forward to what we can achieve together! ? Announcing our collaboration with …See details»